MPT: Gene Therapy Flops for Critical Limb Ischemia

ACC Conference Reporter

ACC.18 | ORLANDO, FL — A novel gene therapy treatment for critical limb ischemia — the non-viral DNA plasmid-based therapy encoding for stromal cell-derived factor-1, dubbed JVS-100 — did not improve wound healing when added to revascularization, researchers reported here. Read More >>>

Keywords: ACC18, ACC Annual Scientific Session

< Back to Listings